Related Experiment Video
Updated: Sep 12, 2025

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
Published on: February 21, 2025
Loop Diuretics and Sarcopenia: A Potential Association.
Nikolaos D Karakousis1, Petros N Georgakopoulos2
1Independent Researcher, Vrilissia 15235, Greece.
Loop diuretics (LDs) may increase sarcopenia risk in patients with chronic kidney disease (CKD) and heart failure (HF). This review suggests a potential link between LD use and muscle wasting, warranting further investigation.
Area of Science:
- Gerontology
- Pharmacology
- Nephrology
Background:
- Loop diuretics (LDs) are commonly prescribed for heart failure (HF), liver cirrhosis, and chronic kidney disease (CKD).
- Sarcopenia, characterized by muscle mass and strength loss, leads to adverse outcomes like frailty, falls, and increased mortality.
Purpose of the Study:
- To investigate the potential association between loop diuretic (LD) use and the development of sarcopenia.
- To synthesize current evidence on the relationship between LDs and muscle wasting across different patient populations.
Main Methods:
- A non-systematic review of existing literature was conducted.
- The review focused on studies examining LD use in conjunction with sarcopenia or related muscle health indicators.
Main Results:
- Loop diuretic use was significantly associated with an increased risk of sarcopenia in non-dialysis-dependent CKD (NDD-CKD) patients.
- Patients with HF on LDs exhibited smaller limb circumferences, suggesting muscle wasting.
- Anorexic patients on diuretics and those with liver cirrhosis showed higher sarcopenia prevalence, with inverse correlation between LD dosage and muscle area in cirrhotic subjects.
Conclusions:
- Evidence suggests a potential link between loop diuretic use and sarcopenia.
- Further research is necessary to confirm the interplay between LDs and sarcopenia and its clinical implications.
More Related Videos
13:35Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos
Published on: March 21, 2021
12:59Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
Published on: July 5, 2017
Related Concept Videos
Heart Failure Drugs: Diuretics
Antihypertensive Drugs: Potassium-Sparing Diuretics
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Thiazide-Class Diuretics
Antihypertensive Drugs: Action of Diuretics
Heart Failure II: Pathophysiology